Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Cash Flow Quality Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow Quality Index of 3.76x as of September 2025. Operating cash flow of CN¥486.04 Million exceeds net income of CN¥129.10 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Shyndec Pharmaceutical Co Ltd (600420) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow Quality Index (2004–2025)
Historical Cash Flow Quality Index for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shanghai Shyndec Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow Quality Index for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year earnings quality comparison for Shanghai Shyndec Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.80x | CN¥1.70 Billion | CN¥944.38 Million | ▲ +6.2% |
| 2024 | 1.69x | CN¥2.26 Billion | CN¥1.33 Billion | ▼ -5.0% |
| 2023 | 1.78x | CN¥1.72 Billion | CN¥964.61 Million | ▼ -60.8% |
| 2022 | 4.55x | CN¥2.86 Billion | CN¥627.79 Million | ▲ +53.9% |
| 2021 | 2.96x | CN¥1.68 Billion | CN¥568.28 Million | ▲ +70.5% |
| 2020 | 1.73x | CN¥1.56 Billion | CN¥900.05 Million | ▲ +26.7% |
| 2019 | 1.37x | CN¥1.27 Billion | CN¥928.47 Million | ▼ -12.3% |
| 2018 | 1.56x | CN¥1.67 Billion | CN¥1.07 Billion | ▼ -44.8% |
| 2017 | 2.83x | CN¥2.31 Billion | CN¥818.57 Million | ▲ +188.0% |
| 2016 | 0.98x | CN¥838.58 Million | CN¥854.03 Million | ▲ +26.3% |
| 2015 | 0.78x | CN¥226.65 Million | CN¥291.55 Million | ▼ -25.6% |
| 2014 | 1.04x | CN¥258.51 Million | CN¥247.54 Million | ▼ -5.6% |
| 2013 | 1.11x | CN¥207.50 Million | CN¥187.51 Million | ▼ -13.2% |
| 2012 | 1.28x | CN¥193.41 Million | CN¥151.67 Million | ▲ +37.6% |
| 2011 | 0.93x | CN¥136.12 Million | CN¥146.92 Million | ▲ +7.2% |
| 2010 | 0.86x | CN¥115.11 Million | CN¥133.12 Million | ▼ -3.5% |
| 2009 | 0.90x | CN¥97.43 Million | CN¥108.70 Million | ▲ +12.1% |
| 2008 | 0.80x | CN¥58.04 Million | CN¥72.58 Million | ▲ +9.9% |
| 2007 | 0.73x | CN¥82.31 Million | CN¥113.11 Million | ▼ -34.5% |
| 2006 | 1.11x | CN¥73.60 Million | CN¥66.29 Million | ▲ +35.3% |
| 2005 | 0.82x | CN¥57.90 Million | CN¥70.53 Million | ▲ +134.7% |
| 2004 | 0.35x | CN¥17.02 Million | CN¥48.66 Million | — |